Literature DB >> 19055374

Asymmetric radical and anionic cyclizations of axially chiral carbamates.

David B Guthrie1, Dennis P Curran.   

Abstract

Standard Boc, Alloc, and Cbz derivatives of N-2,4-dimethyl-6-iodophenyl-N-allyl anilines are axially chiral and can be readily resolved into atropisomers whose racemization barriers exceed 30 kcal/mol. The resolved axially chiral carbamates undergo radical and anionic cyclizations with high levels of chirality transfer from the N-Ar axis to the new stereocenter in the substituted dihydroindole products. The carbamate groups of the products are readily removed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19055374     DOI: 10.1021/ol802616u

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Rotational isomers of N-methyl-N-arylacetamides and their derived enolates: implications for asymmetric Hartwig oxindole cyclizations.

Authors:  Jérémie Mandel; Xiaohong Pan; E Ben Hay; Steven J Geib; Craig S Wilcox; Dennis P Curran
Journal:  J Org Chem       Date:  2013-04-09       Impact factor: 4.354

2.  Synthesis of highly enantioenriched 3,4-dihydroquinolin-2-ones by 6-exo-trig radical cyclizations of axially chiral alpha-halo-ortho-alkenyl anilides.

Authors:  David B Guthrie; Steven J Geib; Dennis P Curran
Journal:  J Am Chem Soc       Date:  2009-10-28       Impact factor: 15.419

3.  Improved Access to Chiral Tetranaphthoazepinium-Based Organocatalysts Using Aqueous Ammonia as Nitrogen Source.

Authors:  Auraya Manaprasertsak; Sorachat Tharamak; Christina Schedl; Alexander Roller; Michael Widhalm
Journal:  Molecules       Date:  2019-10-25       Impact factor: 4.411

4.  Mini-ISES identifies promising carbafructopyranose-based salens for asymmetric catalysis: Tuning ligand shape via the anomeric effect.

Authors:  Kannan R Karukurichi; Xiang Fei; Robert A Swyka; Sylvain Broussy; Weijun Shen; Sangeeta Dey; Sandip K Roy; David B Berkowitz
Journal:  Sci Adv       Date:  2015-07-10       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.